Chemours (CC) Posts Q2 GAAP Loss of 10c/Share

Chemours (NYSE: CC) reported Q2 EPS of ($0.10), which may not compare with the analyst estimate of $0.41. Revenue for the quarter came in at $1.5 billion versus the consensus estimate of $1.53 billion.

For earnings history and earnings-related data on Chemours (CC) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Deutsche Bank Starts DexCom (DXCM) at Buy
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold